Ultragenyx Pharmaceutical Inc. | TalkMarkets

Latest Posts

Stocks Fall As Bond Yields Hit Multi-Year Highs

Article By: Schaeffers Research

Wednesday, October 18, 2023 12:12 PM EDT

The major indexes are firmly lower this afternoon, with both the Dow Jones Industrial Average and Nasdaq Composite down triple digits as bond yields rise.

In this article: COP, QQQ, SPX, VIX, DJI, RARE, FRLN

Read

CNS Pharmaceuticals Commences Patient Enrollment In Potentially Pivotal Study Of Berubicin

Article By: TalkMarkets Newswire

Wednesday, May 19, 2021 10:04 AM EDT

CNS Pharmaceuticals today announced open enrollment for its potentially pivotal study evaluating the efficacy and safety of Berubicin in the treatment of recurrent GBM.

In this article: CNSP Also: ONTX, RARE, SEEL, AUVI, GTBP

Read

AskSlim Market Week - Friday, Feb. 12

Video By: Steve Miller

Friday, February 12, 2021 4:29 PM EDT

Technical and cycle analysis, and market commentary.

In this video: CREE, GLD, IWM, SPX, RARE, TWLO, RDFN, ROKU

Watch

The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings

Article By: Benzinga

Sunday, July 26, 2020 4:29 PM EDT

Although there were promising updates from some coronavirus vaccine makers, negative headlines plagued Novavax, Inc. and Moderna Inc., sending their stocks lower by 4.7% and 23%, respectively, for the week.